Thus, both decreased expression and modulation of SP-A’s and SP-D’s anti-viral activity could play roles in the increased susceptibility of smokers and COPD patients to viral LRTI. The gene discussed is SFTPA2; the disease is chronic obstructive pulmonary disease.